AXA financials
AXA
Country: FR Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
F5WCUMTUM4RKZ1MAIE39 Financial statements
(EUR, as reported — unscaled; 102 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €91.14B | €87.30B |
| Operating profit (EBIT) | €10.37B | €10.41B |
| Profit before tax | €10.00B | €9.98B |
| Income tax expense | €2.37B | €2.46B |
| Profit for the year | €9.98B | €8.07B |
| — attributable to owners | €9.80B | €7.89B |
| — attributable to NCI | €184.0M | €188.0M |
| Total comprehensive income | €7.41B | €7.65B |
| Per share | ||
| Basic EPS | €4.54 | €3.51 |
| Diluted EPS | €4.53 | €3.50 |
| Cash flow statement | ||
| Income taxes paid | €1.26B | €1.82B |
| Dividends paid | €4.73B | €4.46B |
| Balance sheet | ||
| Total assets | €635.54B | €653.76B |
| Intangible assets & goodwill | €22.21B | €22.56B |
| Cash & equivalents | €22.25B | €18.99B |
| Total equity | €49.56B | €52.48B |
| — attributable to owners | €47.17B | €49.94B |
| Non-controlling interests | €2.39B | €2.54B |
| Deferred tax liabilities | €2.11B | €1.98B |
| Derived metrics | ||
| Operating margin | 11.4% | 11.9% |
| Net margin | 11.0% | 9.2% |
| Return on equity | 20.1% | 15.4% |
| Other reported items | ||
| Adjustments For Dividend Income | €3.93B | €3.47B |
| Adjustments For Fair Value Gains Losses | -€4.18B | -€7.23B |
| Adjustments For Increase Decrease In Insurance Reinsurance and Investment Contract Liabilities | €12.80B | -€4.44B |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€2.59B | -€649.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €257.0M | €173.0M |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €28.85B | €30.25B |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €20.97B | €18.11B |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €4.87B | €194.0M |
| Cash Flows From Used In Financing Activities Continuing Operations | -€8.99B | -€7.33B |
| Cash Flows From Used In Investing Activities Continuing Operations | -€10.95B | -€11.25B |
| Cash Flows From Used In Operating Activities Continuing Operations | €22.35B | €12.47B |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €725.0M | €53.0M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €24.05B | €26.15B |
| Comprehensive Income Attributable To Noncontrolling Interests | €121.0M | €136.0M |
| Comprehensive Income Attributable To Owners of Parent | €7.29B | €7.52B |
| Current Tax Assets | €767.0M | €822.0M |
| Current Tax Liabilities | €1.61B | €1.29B |
| Deferred Tax Assets | €2.23B | €3.36B |
| Derivative Financial Assets | €6.88B | €7.82B |
| Derivative Financial Liabilities | €9.63B | €11.68B |
| Dividends Received Classified As Operating Activities | €5.64B | €5.12B |
| Dividends Recognised As Distributions To Owners Per Share | €2.15 | €1.98 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €130.0M | €280.0M |
| Equity and Liabilities | €635.54B | €653.76B |
| Finance Income Expenses From Reinsurance Contracts Held Recognised In Profit Or Loss | €362.0M | €582.0M |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | €4.43B | €7.26B |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €200.0M | €346.0M |
| Impairment Loss Recognised In Profit Or Loss Intangible Assets and Goodwill | €0 | €0 |
| Income Expenses From Reinsurance Contracts Held Other Than Finance Income Expenses | -€3.10B | -€4.26B |
| Increase Decrease In Cash and Cash Equivalents Discontinued Operations | €318.0M | -€589.0M |
| Increase Decrease In Number of Shares Outstanding | -124.2M | -55.4M |
| Increase Decrease Through Sharebased Payment Transactions | €121.0M | €83.0M |
| Increase Decrease Through Transactions With Owners | -€10.33B | -€7.57B |
| Increase Decrease Through Transfers and Other Changes Equity | -€441.0M | -€481.0M |
| Increase Decrease Through Treasury Share Transactions | -€97.0M | -€115.0M |
| Insurance Contracts Issued That Are Assets | €0 | €5.0M |
| Insurance Contracts Issued That Are Liabilities | €470.38B | €477.04B |
| Insurance Finance Income Expenses From Insurance Contracts Issued Recognised In Profit Or Loss | -€14.70B | -€16.85B |
| Insurance Revenue | €89.95B | €86.08B |
| Insurance Service Expenses From Insurance Contracts Issued | €77.85B | €73.77B |
| Intangible Assets Other Than Goodwill | €4.41B | €4.42B |
| Interest Expense On Debt Instruments Issued | €627.0M | €607.0M |
| Interest Received Classified As Operating Activities | €13.30B | €14.51B |
| Investment Accounted For Using Equity Method | €1.48B | €1.53B |
| Investment Contracts Liabilities | €12.84B | €12.57B |
| Investments For Risk of Policyholders | €97.22B | €90.09B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €1.39B |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €233.0M | €4.55B |
| Number of Shares Outstanding | 2090.6M | 2214.8M |
| Other Adjustments For Noncash Items | €529.0M | €267.0M |
| Other Comprehensive Income | -€2.57B | -€421.0M |
| Other Comprehensive Income Net of Tax Change In Fair Value of Financial Liability Attributable To Change In Credit Risk of Liability | -€3.0M | €0 |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€3.56B | €1.35B |
| Other Comprehensive Income Net of Tax Finance Income Expenses From Reinsurance Contracts Held Excluded From Profit Or Loss | €46.0M | -€36.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€350.0M | -€56.0M |
| Other Comprehensive Income Net of Tax Insurance Finance Income Expenses From Insurance Contracts Issued Excluded From Profit Or Loss That Will Be Reclassified To Profit Or Loss | €5.74B | €305.0M |
| Other Comprehensive Income Net of Tax Insurance Finance Income Expenses From Insurance Contracts Issued Excluded From Profit Or Loss That Will Not Be Reclassified To Profit Or Loss | -€318.0M | -€380.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€1.84B | -€638.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€729.0M | €217.0M |
| Other Expense By Function | €2.98B | €2.56B |
| Other Operating Income Expense | -€382.0M | -€250.0M |
| Other Payables | €14.02B | €12.85B |
| Other Receivables | €9.93B | €9.90B |
| Other Revenue | €992.0M | €979.0M |
| Par Value Per Share | €2.29 | €2.29 |
| Proceeds From Issue of Bonds Notes and Debentures | €1.75B | €776.0M |
| Proceeds From Sales of Investment Property | €2.41B | €2.52B |
| Profit Loss From Continuing Operations | €7.63B | €7.52B |
| Profit Loss From Discontinued Operations | €2.35B | €555.0M |
| Property Plant and Equipment Including Rightofuse Assets | €2.15B | €2.21B |
| Provisions | €4.60B | €4.88B |
| Purchase of Investment Property | €3.51B | €2.26B |
| Reinsurance Contracts Held That Are Assets | €23.93B | €26.08B |
| Reinsurance Contracts Held That Are Liabilities | €7.0M | €6.0M |
| Repayments of Bonds Notes and Debentures | €0 | €0 |
| Repayments of Regulatory Capital Equity | €7.29B | €4.73B |
| Repurchase Agreements and Cash Collateral On Securities Lent | €30.50B | €33.06B |
| Retained Earnings Profit Loss For Reporting Period | €9.80B | €7.89B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €257.0M | €173.0M |
| Subordinated Liabilities At Amortised Cost | €12.58B | €11.19B |
Methodology
Every line item above is a fact tagged in AXA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.